106 related articles for article (PubMed ID: 22327716)
61. Rat cisterna magna double-injection model of subarachnoid hemorrhage - background, advantages/limitations, technical considerations, modifications, and outcome measures.
Güresir E; Schuss P; Borger V; Vatter H
Acta Neurochir Suppl; 2015; 120():325-9. PubMed ID: 25366646
[TBL] [Abstract][Full Text] [Related]
62. Sympathetic block for vasospasm.
Day AL; Theodosopoulos PV
Stroke; 2003 Apr; 34(4):961-7. PubMed ID: 12680389
[No Abstract] [Full Text] [Related]
63. Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage.
Hvas CL; Hvas AM
Semin Thromb Hemost; 2022 Oct; 48(7):828-841. PubMed ID: 36100233
[TBL] [Abstract][Full Text] [Related]
64. [Effect of external decompression on the development of delayed ischemic neurological deficits after subarachnoid hemorrhage].
Miyata I; Tsuno K; Masaoka T; Nishiura T; Harada Y; Ishimitsu H
Neurol Med Chir (Tokyo); 1989 Aug; 29(8):735-9. PubMed ID: 2479868
[TBL] [Abstract][Full Text] [Related]
65. In vitro study of cerebrospinal fluid dynamics in a shaken basal cistern after experimental subarachnoid hemorrhage.
Kertzscher U; Schneider T; Goubergrits L; Affeld K; Hänggi D; Spuler A
PLoS One; 2012; 7(8):e41677. PubMed ID: 22870243
[TBL] [Abstract][Full Text] [Related]
66. The use of mild hypothermia for patients with severe vasospasm: a preliminary report.
Nagao S; Irie K; Kawai N; Nakamura T; Kunishio K; Matsumoto Y
J Clin Neurosci; 2003 Mar; 10(2):208-12. PubMed ID: 12637050
[TBL] [Abstract][Full Text] [Related]
67. The Complementary Role of CT Perfusion and Transcranial Doppler in the Assessment of Delayed Cerebral Ischemia after Aneurysmal SAH.
Quintas-Neves M
AJNR Am J Neuroradiol; 2022 Mar; 43(3):E3. PubMed ID: 35241424
[No Abstract] [Full Text] [Related]
68. Gene therapy for cerebral vascular disease: update 2003.
Toyoda K; Chu Y; Heistad DD
Br J Pharmacol; 2003 May; 139(1):1-9. PubMed ID: 12746217
[TBL] [Abstract][Full Text] [Related]
69. Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study.
Ohta T; Kikuchi H; Hashi K; Kudo Y
J Neurosurg; 1986 Mar; 64(3):420-6. PubMed ID: 3512795
[TBL] [Abstract][Full Text] [Related]
70. [Intravenous thrombolysis in capsular warning syndrome: is it beneficial?].
Gutiérrez Ruano B; García Pastor A; Villanueva Osorio JA; Bravo Quelle N; Vázquez Alén P; Díaz Otero F; Gil Núñez A
Neurologia; 2013 Sep; 28(7):444-6. PubMed ID: 22652144
[No Abstract] [Full Text] [Related]
71. Reversible parinaud syndrome following intraventricular thrombolysis.
Laforce R; Khuong H; Gariépy JL; Milot G; Savard M
Can J Neurol Sci; 2009 Jan; 36(1):95-7. PubMed ID: 19294897
[No Abstract] [Full Text] [Related]
72. Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics.
Naff NJ; Williams MA; Rigamonti D; Keyl PM; Hanley DF
Neurosurgery; 2001 Sep; 49(3):614-9; discussion 619-21. PubMed ID: 11523671
[TBL] [Abstract][Full Text] [Related]
73. Thrombolytic Removal of Intraventricular Hemorrhage in Treatment of Severe Stroke: Results of the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Trial.
Alvarez CM; Starke RM; Komotar RJ; Connolly ES
Neurosurgery; 2017 Jul; 81(1):N6-N7. PubMed ID: 28873991
[No Abstract] [Full Text] [Related]
74. Targeting Hemoglobin to Reduce Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.
Zeineddine HA; Honarpisheh P; McBride D; Pandit PKT; Dienel A; Hong SH; Grotta J; Blackburn S
Transl Stroke Res; 2022 Oct; 13(5):725-735. PubMed ID: 35157256
[TBL] [Abstract][Full Text] [Related]
75. The Effect of Locally Administered Fibrinolytic Drugs Following Aneurysmal Subarachnoid Hemorrhage : A Meta-Analysis with Eight Randomized Controlled Studies.
Jang KM; Choi HH; Nam TK; Park YS; Kwon JT; Byun JS; Hwang D
J Korean Neurosurg Soc; 2021 Mar; 64(2):207-216. PubMed ID: 33626858
[TBL] [Abstract][Full Text] [Related]
76. Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?
Kiser TH
Hosp Pharm; 2014 Nov; 49(10):923-41. PubMed ID: 25477565
[TBL] [Abstract][Full Text] [Related]
77. The effect of intraventricular thrombolysis in combination with low-frequency head motion after severe subarachnoid hemorrhage: interim analysis of safety, clot clearance rate and delayed cerebral ischemia.
Eicker SO; Beseoglu K; Etminan N; Perrin J; Taskin A; Steiger HJ; Hänggi D
Acta Neurochir Suppl; 2012; 114():323-8. PubMed ID: 22327716
[TBL] [Abstract][Full Text] [Related]
78. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
[TBL] [Abstract][Full Text] [Related]
79. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial.
Hänggi D; Liersch J; Turowski B; Yong M; Steiger HJ
J Neurosurg; 2008 Jun; 108(6):1192-9. PubMed ID: 18518727
[TBL] [Abstract][Full Text] [Related]
80. Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage.
Ibrahim GM; Vachhrajani S; Ilodigwe D; Kassell NF; Mayer SA; Ruefenacht D; Schmiedek P; Weidauer S; Pasqualin A; Macdonald RL
Neurosurgery; 2012 Jan; 70(1):102-9; discussion 109. PubMed ID: 21788917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
